Arcturus Therapeutics Holdings Inc (ARCT)
26.98
-0.95
(-3.40%)
USD |
NASDAQ |
Apr 24, 16:00
26.98
0.00 (0.00%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Total Assets (Quarterly): 429.40M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 429.40M |
| September 30, 2023 | 457.65M |
| June 30, 2023 | 430.65M |
| March 31, 2023 | 470.86M |
| December 31, 2022 | 450.39M |
| September 30, 2022 | 293.63M |
| June 30, 2022 | 337.01M |
| March 31, 2022 | 341.99M |
| December 31, 2021 | 392.81M |
| September 30, 2021 | 434.54M |
| June 30, 2021 | 448.81M |
| March 31, 2021 | 481.47M |
| December 31, 2020 | 476.46M |
| September 30, 2020 | 322.52M |
| June 30, 2020 | 149.94M |
| March 31, 2020 | 72.10M |
| December 31, 2019 | 82.14M |
| September 30, 2019 | 87.22M |
| June 30, 2019 | 70.94M |
| March 31, 2019 | 44.42M |
| December 31, 2018 | 44.20M |
| Date | Value |
|---|---|
| September 30, 2018 | 37.12M |
| June 30, 2018 | 44.32M |
| December 31, 2017 | 52.02M |
| September 30, 2017 | 40.59M |
| June 30, 2017 | 42.35M |
| March 31, 2017 | 46.42M |
| December 31, 2016 | 13.74M |
| September 30, 2016 | 55.91M |
| June 30, 2016 | 62.69M |
| March 31, 2016 | 67.10M |
| December 31, 2015 | 71.68M |
| September 30, 2015 | 37.65M |
| June 30, 2015 | 41.62M |
| December 31, 2014 | 22.32M |
| September 30, 2014 | 30.86M |
| June 30, 2014 | 40.17M |
| March 31, 2014 | 45.60M |
| December 31, 2013 | 50.32M |
| September 30, 2013 | 19.80M |
| June 30, 2013 | 21.70M |
| December 31, 2012 | 0.201M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
70.94M
Minimum
Jun 2019
481.47M
Maximum
Mar 2021
327.92M
Average
392.81M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 19.38M |
| Perspective Therapeutics Inc | 97.89M |
| Protalix BioTherapeutics Inc | 84.43M |
| Electromed Inc | 46.96M |
| Armata Pharmaceuticals Inc | 98.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 150.89M |
| Shareholders Equity (Quarterly) | 278.51M |
| Current Ratio | 4.715 |
| Net Debt Paydown Yield | 1.41% |